Dose-Escalation Study to Evaluate the Safety and Immunogenicity of MTBVAC Vaccine in Comparison With BCG Vaccine. (MTBVAC)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2013 by Biofabri, S.L.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborators:
Universidad de Zaragoza
Centre Hospitalier Universitaire Vaudois
Tuberculosis Vaccine Initiative (TBVI)
European Union
Information provided by (Responsible Party):
Biofabri, S.L
ClinicalTrials.gov Identifier:
NCT02013245
First received: December 3, 2013
Last updated: December 11, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):